J. Kaplan

发表

Partial restoration of cAMP-stimulated CFTR chloride channel activity in ΔF508 cells by deoxyspergualin.

Seng H. Cheng, Canwen Jiang, S. Fang, 1998, American journal of physiology. Cell physiology.

Enhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes

J. Kaplan, J. S. St. George, B. Roberts, 2004, Journal of immunotherapy.

Solid-Phase Epitope Recovery: A High Throughput Method for Antigen Identification and Epitope Optimization

J. Kaplan, B. Roberts, G. J. Franklin, 2002, The Journal of Immunology.

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model

Yanping Hu, J. Kaplan, B. Roberts, 2009, Immunology.

Immune status following alemtuzumab treatment in human CD52 transgenic mice

J. Kaplan, B. Roberts, N. Chrétien, 2013, Journal of Neuroimmunology.

Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.

J. Kaplan, B. Roberts, S. Shankara, 1999, Journal of immunology.

Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung.

R. Scheule, J. Marshall, J. Kaplan, 1997, Human gene therapy.

Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.

J. Kaplan, K. Smith, B. Roberts, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models

Yanping Hu, J. Kaplan, B. Roberts, 2010, Leukemia & lymphoma.

Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype

J. Kaplan, L. Gooding, A. Smith, 1997, Journal of virology.

Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals.

K. Walsh, J. Kaplan, M. Sata, 1999, Circulation.

Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung.

J. Kaplan, A. Smith, A. Smith, 1997, Human gene therapy.

Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro

J. Kaplan, B. Roberts, Juanita Campos-Rivera, 2014, Immunology.

Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy

B. Teicher, J. Kaplan, M. Yao, 2011, Clinical Cancer Research.

This information is current as Identification and Epitope Optimization Throughput Method for Antigen Solid-Phase Epitope Recovery : A High

J. Kaplan, B. Roberts, C. Nicolette, 2002 .

Immunomodulatory activity of mesenchymal stem cells.

J. Kaplan, T. Lodie, M. Youd, 2011, Current stem cell research & therapy.

Tumor-Associated Antigens Vector-Encoding Endogenous Dendritic Cells Transduced with Adenovirus Induction of Antitumor Immunity with

J. Kaplan, B. Roberts, S. Shankara, 1999 .

Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis

Sambasiva P Rao, J. Kaplan, B. Roberts, 2012, PloS one.

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.

P. A. Peterson, J. Kaplan, L. Gooding, 1997, Human gene therapy.

Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.

J. Kaplan, M. Lukason, S. Wadsworth, 2009, Human gene therapy.

Two distinct antigen-specific suppressor factors induced by the oral administration of antigen

C. Janeway, J. Kaplan, J. Mattingly, 1980, The Journal of experimental medicine.

Development of an in vivo antibody-mediated killing (IVAK) model, a flow cytometric method to rapidly evaluate therapeutic antibodies.

J. Kaplan, M. Perricone, Karen A. Smith, 2008, Journal of immunological methods.

Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis

Petti T. Pang, J. Kaplan, B. Roberts, 2015, Journal of Neuroimmunology.

Biological response of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.

P. A. Peterson, J. Kaplan, A. Smith, 1996, Gene therapy.

Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo

H. Zhou, H. Zhou, J. Kaplan, 1997, Journal of virology.

Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists

Yanping Hu, J. Kaplan, Robert Fogle, 2012, Leukemia & lymphoma.

Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates.

J. Morris, J. Kaplan, M. Lukason, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells.

J. Kaplan, J. S. St. George, K. Smith, 2000, Human gene therapy.

Adenovirus-Mediated Persistent Cystic Fibrosis Transmembrane Conductance Regulator Expression in Mouse Airway Epithelium

Canwen Jiang, J. Kaplan, J. S. St. George, 1998, Journal of Virology.

Induction of Antitumor Immunity by Semi‐Allogeneic and Fully Allogeneic Electrofusion Products of Tumor Cells and Dendritic Cells

J. Kaplan, W. Siders, J. Shields, 2009, Clinical and translational science.

Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.

R. Johnson, J. Kaplan, A. Smith, 1996, Gene therapy.

Novel Role for E4 Region Genes in Protection of Adenovirus Vectors from Lysis by Cytotoxic T Lymphocytes

J. Kaplan, Alan E. Smith, S. Wadsworth, 1999, Journal of Virology.

Lysis by Cytotoxic T Lymphocytes Protection of Adenovirus Vectors from Novel Role for E 4 Region Genes in

J. Kaplan, Alan E. Smith, D. Armentano, 1999 .

Novel Role for E 4 Region Genes in Protection of Adenovirus Vectors from Lysis by Cytotoxic T Lymphocytes

J. Kaplan, Alan E. Smith, S. Wadsworth, 1999 .

Lowering Glycosphingolipid Levels in CD4+ T Cells Attenuates T Cell Receptor Signaling, Cytokine Production, and Differentiation to the Th17 Lineage*

J. Shayman, W. Chuang, Seng H. Cheng, 2011, The Journal of Biological Chemistry.

Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential.

A E Smith, J. Marshall, J. Kaplan, 1998, Human gene therapy.

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

A. Bar-Or, H. Wiendl, J. Kaplan, 2014, Drugs.

Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.

M. Freedman, J. Kaplan, S. Markovic‐Plese, 2013, Journal of clinical & cellular immunology.

Tumor treatment with complexes of cationic lipid and noncoding plasmid DNA results in the induction of cytotoxic T cells and systemic tumor elimination.

R. Scheule, J. Kaplan, W. Siders, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis

J. Kaplan, M. Perricone, John M. Williams, 2011, Journal of Neuroimmunology.

Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia

B. Teicher, S. Madden, P. Nambiar, 2012, International journal of oncology.

Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells.

Jacqueline Shields, J. Kaplan, William M Siders, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes

S. Madden, J. Kaplan, B. Roberts, 2012, Leukemia & lymphoma.

Natural killer cell activity in multiple sclerosis and myasthenia gravis.

J. Kaplan, I. N. Montgomery, H. Rauch, 1985, Immunological investigations.

sFLT01: A Novel Fusion Protein with Antiangiogenic Activity

B. Teicher, J. Kaplan, M. Yao, 2011, Molecular Cancer Therapeutics.

Therapeutic Discovery sFLT 01 : A Novel Fusion Protein with Antiangiogenic Activity

B. Teicher, J. Kaplan, M. Yao, 2011 .

Cytotoxic T-Lymphocyte (CTL) responses to the transgene product and not AAV capsid protein limit transgene expression in mice

J. Kaplan, M. Lukason, S. Wadsworth, 2008 .

Adenovirus-based cancer gene therapy.

J. Kaplan, Johanne M Kaplan, 2005, Current gene therapy.

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

I. Mackenzie, S. Plotkin, Xu-biao Peng, 2019, Scientific Reports.

Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species

J. Kaplan, D. Jorkasky, P. Bugelski, 1996, Journal of Clinical Immunology.

Abstract 3826: Neutralization of TGFβ enhances the efficacy of chemotherapeutics in a preclinical model of triple negative breast cancer

L. Wakefield, J. McPherson, J. Kaplan, 2010 .

Abstract B244: Inhibition of metastases by a neutralizing TGFβ‐specific antibody involves the activity of cytotoxic T lymphocytes and natural killer cells

J. Pinkas, J. McPherson, J. Kaplan, 2009 .

Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin.

S. Fang, S. Nadler, D. Jefferson, 1998, The American journal of physiology.

Cationic Lipid-Mediated Gene Therapy

Seng H. Cheng, J. Kaplan, W. Siders, 2002 .

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.

A. Beaudet, S. Kochanek, H. Zhou, 1999, Proceedings of the National Academy of Sciences of the United States of America.

GZ402668, a Next-Generation Anti-CD52 Antibody, Displays Decreased Proinflammatory Cytokine Release In Vitro (P3.068)

V. Dhawan, R. Sendak, J. Kaplan, 2016 .

Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice.

J. Kaplan, S. Ponnazhagan, A. Srivastava, 1997, Gene.

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

I. Mackenzie, S. Plotkin, Xu-biao Peng, 2019, Scientific Reports.

Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate.

O. Raabe, J. Kaplan, M. Lukason, 1997, Human gene therapy.

Alemtuzumab activity and CD52 expression in human CD52 transgenic mice

Yanping Hu, J. Kaplan, B. Roberts, 2007 .

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model

Yanping Hu, J. Kaplan, B. Roberts, 2009, Immunology.